Thomas Jefferson University
Single vaccines to protect against both rabies and Ebola
Researchers from Thomas Jefferson University, among other institutions, including the National Institute of Allergy and Infectious Diseases, have developed single vaccines to protest against both rabies and ...
Medical research
Aug 25, 2011 |
5 / 5 (4) |
1
|
Could a tumor suppressor also fight obesity?
The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country's biggest ...
Medical research
Aug 25, 2011 |
not rated yet |
0
|
Increase in infection rates in patients with cardiac electrophysiological devices
New research from the Jefferson Heart Institute shows that patients in the United States who receive cardiac electrophysiological devices (CIEDs), including permanent pacemakers and implantable cardioverter-defibrillators ...
Cardiology
Aug 22, 2011 |
5 / 5 (1) |
0
|
Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells
Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme ...
Cancer
Aug 10, 2011 |
5 / 5 (1) |
0
|
Leukemia drug reverses tamoxifen-resistance in breast cancer cells
Taking a leukemia chemotherapy drug may help breast cancer patients who don't respond to tamoxifen overcome resistance to the widely-used drug, new research from the Kimmel Cancer Center at Jefferson suggests. ...
Cancer
Aug 01, 2011 |
not rated yet |
0
|
Gene therapy to reverse heart failure ready for clinical trials
A promising gene therapy developed, in part, at Thomas Jefferson University's Center for Translational Medicine to prevent and reverse congestive heart failure is on the verge of clinical trials, after years of proving itself ...
Genetics
Jul 20, 2011 |
not rated yet |
0
|
Radiation after prostate removal is cost-effective, but less likely to be recommended by urologists
Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according ...
Cancer
Jun 09, 2011 |
5 / 5 (1) |
0
Emerging trends in radiation therapy for women over 70 with early stage breast cancer
Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting ...
Cancer
Jun 02, 2011 |
not rated yet |
0
Glioblastoma in the 21st century: Wealthier patients living longer than poorer patients
Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than ...
Cancer
Jun 02, 2011 |
not rated yet |
0
ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from ...
Cancer
Jun 02, 2011 |
not rated yet |
0
Cancer cells accelerate aging and inflammation in the body to drive tumor growth
Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow—and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby ...
Cancer
May 26, 2011 |
5 / 5 (1) |
0
Marker identifies breast cancer patients likely to respond to tamoxifen
Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.
Cancer
May 18, 2011 |
not rated yet |
0
Blocking crucial molecule could help treat multiple sclerosis
Reporting in Nature Immunology, Jefferson neuroscientists have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step i ...
Medical research
Apr 24, 2011 |
4.5 / 5 (4) |
1
|
Minimizing side effects from chemoradiation could help brain cancer patients live longer
Minimizing neurological side effects in patients with high-grade glioma from chemoradiation may result in improved patient survival, a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests. ...
Cancer
Apr 19, 2011 |
not rated yet |
0
FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool
The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from ...
Other
Apr 18, 2011 |
5 / 5 (1) |
0
